CG Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$6.83M Sell
59,000
-1,900
-3% -$212K 2.55% 5
2016
Q3
$6.37M Sell
60,900
-4,590
-7% -$497K 2.38% 5
2016
Q2
$6.46M Sell
65,490
-175
-0.3% -$18.1K 2.59% 6
2016
Q1
$6.57M Buy
65,665
+1,030
+2% +$106K 2.63% 6
2015
Q4
$7.74M Sell
64,635
-1,495
-2% -$173K 3.08% 6
2015
Q3
$7.15M Buy
66,130
+570
+0.9% +$70.7K 3.02% 6
2015
Q2
$7.59M Buy
65,560
+1,950
+3% +$223K 2.89% 6
2015
Q1
$7.33M Buy
63,610
+110
+0.2% +$13.1K 2.85% 3
2014
Q4
$7.1M Buy
63,500
+2,300
+4% +$243K 2.8% 4
2014
Q3
$5.8M Buy
61,200
+1,500
+3% +$135K 2.39% 7
2014
Q2
$5.13M Buy
59,700
+3,950
+7% +$300K 2.17% 11
2014
Q1
$3.89M Buy
55,750
+600
+1% +$47.5K 1.75% 17
2013
Q4
$4.66M Buy
+55,150
New +$4.36M 2.13% 9

Other funds holding CELG

CG Asset Management's CELG Position: Q4 2016 in Review

CG Asset Management reduced its Celgene Corp (CELG) stake by 3.1% in Q4 2016, selling an estimated $212K and leaving 59,000 shares worth $6.83M. The position accounts for 2.55% of the portfolio, ranked #5.

CG Asset Management first reported a position in CELG in Q4 2013 and has held it in 13 quarters since. The position peaked at $7.74M in Q4 2015. 1,375 funds tracked by Wall St. Rank hold CELG as of Q4 2016.

  • CG Asset Management held 59,000 shares of Celgene Corp worth $6.83M as of Q4 2016.
  • CG Asset Management sold 1,900 Celgene Corp shares in Q4 2016, an estimated $212K.
  • Celgene Corp made up 2.55% of CG Asset Management's portfolio in Q4 2016, its #5 holding.
  • CG Asset Management first reported a position in Celgene Corp in Q4 2013 and has held it in 13 quarters since.
  • CG Asset Management's Celgene Corp position peaked at $7.74M in Q4 2015.
  • 1,375 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2016.

Based on CG Asset Management's 13F filing for Q4 2016, filed 10 Feb 2017.